An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells
- PMID: 8144523
An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells
Abstract
Lipoprotein lipase (LPL), the principal enzyme which hydrolyzes triglycerides in circulating plasma lipoproteins, functions while bound to the luminal surface of endothelial cells. LPL is a heparin-binding protein and has been assumed to associate with endothelial cell heparan sulfate proteoglycans (HSPG). Recently, using ligand blotting and affinity chromatography we identified a 116-kDa heparin-releasable LPL-binding protein (hrp-116) from endothelial cells which was not a HSPG (Sivaram, P., Klein, M. G., and Goldberg, I. J. (1992) J. Biol. Chem. 267, 16517-16522). This suggested that, like a number of other heparin-binding proteins, LPL binding to cells also involves non-HSPG proteins. Using heparin-agarose affinity chromatography, a 116-kDa LPL-binding protein was purified from endothelial cell extracts. Microsequencing of peptides generated by Lys-C protease digestion revealed complete homology with four different regions in the NH2-terminal part of human apolipoprotein B (apoB). Western blots using anti-apoB monoclonal antibodies (mAb) that recognize the NH2-terminal region of apoB confirmed that a 116-kDa fragment of apoB was present on endothelial cell membranes. Further evidence that LPL associates with the NH2-terminal region of apoB was obtained by showing 1) that an NH2-terminal fragment of apoB obtained from apoB-transfected CHO cells bound LPL on ligand blots and 2) that NH2-terminal fragments of apoB generated by thrombin digestion of low density lipoprotein bind LPL. Evidence that the NH2-terminal region of apoB mediates LPL interaction with endothelial cells was obtained using monoclonal antibodies. mAb3 and mAb19, which recognize epitopes near the NH2 terminus of apoB, inhibited 125I-LPL binding to cells by 60-65%. In contrast, mAb47, which has determinants at the COOH-terminal end of apoB, inhibited LPL binding by only about 10%. The inhibitory effects of mAb3 and mAb19 were abolished following treatment of cells with heparin, which removes the 116-kDa LPL-binding protein. Furthermore, incubation of 125I-LPL in medium containing an NH2-terminal apoB fragment reduced LPL binding to cells. These data suggest that an NH2-terminal fragment of apoB that binds to endothelial surfaces facilitates LPL binding to cells.
Similar articles
-
Cell-surface expression of an amino-terminal fragment of apolipoprotein B increases lipoprotein lipase binding to cells.J Biol Chem. 1996 Aug 9;271(32):19518-23. doi: 10.1074/jbc.271.32.19518. J Biol Chem. 1996. PMID: 8702644
-
Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B.J Biol Chem. 1995 Apr 7;270(14):8081-6. doi: 10.1074/jbc.270.14.8081. J Biol Chem. 1995. PMID: 7713910
-
The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans.J Biol Chem. 1998 Dec 25;273(52):35355-61. doi: 10.1074/jbc.273.52.35355. J Biol Chem. 1998. PMID: 9857078
-
Endothelial cells synthesize and process apolipoprotein B.J Biol Chem. 1996 Jun 21;271(25):15261-6. doi: 10.1074/jbc.271.25.15261. J Biol Chem. 1996. PMID: 8663087
-
GPIHBP1, an endothelial cell transporter for lipoprotein lipase.J Lipid Res. 2011 Nov;52(11):1869-84. doi: 10.1194/jlr.R018689. Epub 2011 Aug 15. J Lipid Res. 2011. PMID: 21844202 Free PMC article. Review.
Cited by
-
Vitellogenin recognizes cell damage through membrane binding and shields living cells from reactive oxygen species.J Biol Chem. 2013 Sep 27;288(39):28369-81. doi: 10.1074/jbc.M113.465021. Epub 2013 Jul 28. J Biol Chem. 2013. PMID: 23897804 Free PMC article.
-
Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins.Cell Mol Biol Lett. 2012 Sep;17(3):459-78. doi: 10.2478/s11658-012-0019-2. Epub 2012 Jun 13. Cell Mol Biol Lett. 2012. PMID: 22706677 Free PMC article.
-
Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.Nutr Metab (Lond). 2010 Apr 27;7:35. doi: 10.1186/1743-7075-7-35. Nutr Metab (Lond). 2010. PMID: 20423497 Free PMC article.
-
Molecular structure of low density lipoprotein: current status and future challenges.Eur Biophys J. 2009 Feb;38(2):145-58. doi: 10.1007/s00249-008-0368-y. Epub 2008 Sep 17. Eur Biophys J. 2009. PMID: 18797861
-
Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.J Lipid Res. 2000 Nov;41(11):1858-71. J Lipid Res. 2000. PMID: 11060356 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous